1. Iniciokeyboard_arrow_right
  2. Equipokeyboard_arrow_right
  3. Dr. Pablo Florenzano V.
Dr. Pablo Florenzano V.

Dr. Pablo Florenzano V.

Profesor Asistente

Departamento de Endocrinología. Facultad de Medicina.
Pontificia Universidad Católica de Chile.

EDUCACIÓN

- Pregrado

  • 1998-2005 Escuela de Medicina.Universidad de Los Andes, Santiago,Chile

- Postgrado

  • 2006-2009 Especialización en Medicina Interna, Pontificia Universidad Católica, Santiago, Chile.
  • 2013-2015 Especialización en Endocrinología, Pontificia Universidad Católica, Santiago, Chile.
  • 2016-2018 Visiting Fellow. Skeletal Disorders and Mineral Homeostasis Section. NIDCR. National Institutes of Health. Bethesda, MD. USA

 

MAIL DE CONTACTO
pflorenz@uc.cl

 

PUBLICACIONES

  1. Hartley IR, Miller CB, Papadakis GZ, Bergwitz C, Del Rivero J, Blau JE, Florenzano P, Berglund JA, Tassone J, Roszko KL, Moran S, Gafni RI, Isaacs R, Collins MT. Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia. N Engl J Med. 2020 Oct 1;383(14):1387-1389. https://pubmed.ncbi.nlm.nih.gov/32905668/
  2. Florenzano P, Cipriani C, Roszko KL, Fukumoto S, Collins MT, Minisola S, Pepe J. Approach to patients with hypophosphatemia. Lancet Diabetes Endocrinol. 2020 Feb;8(2):163-174. https://pubmed.ncbi.nlm.nih.gov/31924563/
  3. Florenzano P, Jimenez M, Ferreira CR, Nesterova G, Roberts MS, Tella SH, Fernandez de Castro L, Gafni RI, Wolf M, Jüppner H, Gales B, Wesseling-Perry K, Markovich D, Gahl WA, Salusky IB, Collins MT. Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23. J Am Soc Nephrol. 2020 Sep;31(9):2184-2192.https://pubmed.ncbi.nlm.nih.gov/32631973/
  4. Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT. Tumor-Induced Osteomalacia. Calcif Tissue Int. 2021 Jan;108(1):128-142. https://pubmed.ncbi.nlm.nih.gov/32504138/
  5. Papadakis GZ, Manikis GC, Karantanas AH, Florenzano P, Bagci U, Marias K, Collins MT, Boyce AM. 18 F-naF Pet/Ct Imaging In Fibrous Dysplasia of Bone. J Bone Miner Res. 2019 Sep;34(9):1619-1631. https://pubmed.ncbi.nlm.nih.gov/31116487/
  6. Florenzano P, Pan KS, Brown SM, Paul SM, Kushner H, Guthrie LC, de Castro LF, Collins MT, Boyce AM. Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone. J Bone Miner Res. 2019 Apr;34(4):653-660. https://pubmed.ncbi.nlm.nih.gov/30645769/
  7. Florenzano P, Ferreira C, Nesterova G, Roberts MS, Tella SH, de Castro LF, Brown SM, Whitaker A, Pereira RC, Bulas D, Gafni RI, Salusky IB, Gahl WA, Collins MT. Skeletal Consequences of Nephropathic Cystinosis. J Bone Miner Res. 2018 Oct;33(10):1870-1880. https://pubmed.ncbi.nlm.nih.gov/29905968/
  8. de Castro LF, Burke AB, Wang HD, Tsai J, Florenzano P, Pan KS, Bhattacharyya N, Boyce AM, Gafni RI, Molinolo AA, Robey PG, Collins MT. Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden. J Bone Miner Res. 2019 Feb;34(2):290-294. https://pubmed.ncbi.nlm.nih.gov/30496606/
  9. González G, Baudrand R, Sepúlveda MF, Vucetich N, Guarda FJ, Villanueva P, Contreras O, Villa A, Salech F, Toro L, Michea L, Florenzano P. Tumor-induced osteomalacia: experience from a South American academic center. Osteoporos Int. 2017 Jul;28(7):2187-2193. https://pubmed.ncbi.nlm.nih.gov/28341900/
  10. Acevedo F, Pérez V, Pérez-Sepúlveda A, Florenzano P, Artigas R, Medina L, Sánchez C. High prevalence of vitamin D deficiency in women with breast cancer: The first Chilean study. Breast. 2016 Oct;29:39-43. https://pubmed.ncbi.nlm.nih.gov/27400446/

CAPÍTULOS DEL LIBRO

  1. Florenzano P, Collins MT. "Tumor Induced Osteomalacia" Edited by Bilezikian, Clemens, Rosen, Clemens. Principles of Bone Biology. Fourth Edition. August 2019
  2. Boyce AM, Florenzano P, F de Castro L, Collins MT. Fibrous Dysplasia/McCune-Albright Syndrome. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.2015 Feb 26 [updated 2018 Aug 16]. https://pubmed.ncbi.nlm.nih.gov/25719192/
  3. Gonzalez G Florenzano P, Osteoporosis post-menopáusica. Manual de Endocrinología Ginecológica. Primera edición.2016. Pag 374-388. Editorial Mediterraneo.
  4. Gonzalez G, Florenzano P, Contreras O. Aproximaximacion al paciente con enfermedades óseas metabólicas. Endocrinología Clínica. Segunda edición. 2017. Editorial Mediterraneo.
  5. Florenzano P, Gonzalez G. Enfermedades del metabolismo del calcio y el fosfato. Endocrinología Clínica. Segunda edición. 2017. Editorial Mediterraneo.

 

PREMIOS Y RECONOCIMIENTOS

  • 2010-2012 Premio al Mejor Docente Clínico. Programa de Medicina Interna. Facultad de Medicina.Universidad Catolica de Chile.
  • 2013 Participant and Travel Award, Endocrine Fellows Foundation Forum in Metabolic Bone Diseases, American Society for Bone and Mineral Research Annual Meeting. Baltimore, MD
  • 2014 Preceptorship in Metabolic Bone Diseases. Columbia University Medical Center. Endocrine Fellows Foundation. Travel Award.
  • 2015 Participant and Travel Award. Early Career Forum, Endocrine Society Annual Meeting. San Diego, CA.
  • 2016 Scholarship “Advanced Specialized International Medical Studies”. Oscar y Elsa Braun Foundation. Chile
  • 2017 Alice L. Jee Young Investigator Award. ORS 47th International
  • 2018 Musculoskeletal Biology Workshop.
    ASBMR Young Investigator award. ASBMR annual meeting.
    Montreal, Canada

PROYECTOS DE INVESTIGACIÓN

  • 2010 Implementación de la metodología de aprendizaje basado en equipos (TBL) en la enseñanza médica. Becas para el desarrollo docente (FONDEDOC). Facultad de Medicina. Universidad Católica de Chile.
  • 2018-2019 Unrestricted research grant. ¨Clinical and Molecular Characterization of Patients With Hereditary Hypophosphatemic Rickets In South America¨. Ultragenyx Pharmaceuticals.
  • 2019-2029 X-linked Hypophosphatemia Disease Monitoring Program. Ultragenyx Pharmaceuticals.
  • 2020-2022 Unrestricted research grant. ¨ Enthesopathy, Osteoarthritis And Muscular InvolvementAnd Its Correlation With Biochemical Abnormalities And Quality Of Life In Patients With X-Linked Hypophosphatemia (XLH)¨.

 

MEMBRESIA SOCIEDADES CIENTIFICAS

  • Sociedad Chilena de Endocrinología y Diabetes
  • Sociedad Chilena de Medicina Interna
  • American Society of Bone and Mineral Research
  • Endocrine Society